Clinical Trial Update: A Pharmacokinetic (PK) Study to Compare the Absorption of Two Formulations of Transdermal Testosterone Spray and Intrinsa® [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study comparing absorption of two formulations of transdermal testosterone spray and Intrinsa was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoactive Sexual Desire Disorder

Drugs mentioned

• Intrinsa (testosterone)
• Transdermal testosterone spray (testosterone)

Snippet

Sponsor: VIVUS LLC | Conditions: Hypoactive Sexual Desire Disorder | Phase 1 | Status: TERMINATED